Nexus BioPharma

Montclair, United States Founded: 2007 • Age: 19 yrs Listed
Therapies for treating obesity and type 2 diabetes.

About Nexus BioPharma

Nexus BioPharma is a publicly listed company based in Montclair (United States) founded in 2007. Therapies for treating obesity and type 2 diabetes. The company has 1 employees. Nexus BioPharma offers products and services including Obesity Therapies and Diabetes Therapies. Its focus areas include Life Sciences, Metabolic Diseases and Drugs. Its legal entity is NEXUS BIOPHARMA INC. Its competitors include NGM Biopharmaceuticals, MannKind Corp and Rhythm Pharmaceuticals; 3 of its 3 listed competitors have raised funding.

Company details

Nexus BioPharma was founded in 2007 as a preclinical-stage biotechnology company located in Montclair, United States. Focus is placed on discovering and developing Fyn kinase inhibitors to activate the LKB1-AMPK metabolic pathway for treating obesity and type 2 diabetes. Operations involve collaboration with BioFocus DPI, a subsidiary of Charles River Laboratories, to advance these therapies.

  • Headquarters Montclair, United States
  • Employees 1
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website nexusbiopharma.com
  • Social X Facebook
  • Legal Name Nexus Biopharma Inc
Operational Areas
Key Metrics
  • Net Profit
    -$686.1 K (USD)
    40
    as on Feb 28, 2017
  • Employee Count
    1

Products & Services of Nexus BioPharma

Nexus BioPharma offers a comprehensive portfolio of products and services, including Obesity Therapies and Diabetes Therapies.

Obesity Therapies
Biotech Products

Preclinical treatments targeting obesity through research and development.

Diabetes Therapies
Biotech Products

Preclinical solutions for type 2 diabetes via innovative drug pipelines.

People of Nexus BioPharma

3 people are tracked at Nexus BioPharma (1 in leadership, 2 in board & advisors); the tracked headcount is 1.

NameRoleGroup
Warren C. Lau
President & CEOLeadership
Jeffrey Pessin
ChairBoard & advisors
Dan Einhorn
Scientific AdvisorBoard & advisors
Premium access

Complete people profiles for Nexus BioPharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Competitors of Nexus BioPharma

Nexus BioPharma has 3 listed competitors in our database, 3 of them funded. They include NGM Biopharmaceuticals, MannKind Corp and Rhythm Pharmaceuticals.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
ngmbio.com2007San Francisco, United States$358.87M225
Biologics are developed for cardio-metabolic and liver diseases.
mannkindcorp.com1991Los Angeles, United States$50M322
Developer of small-molecule drugs
rhythmtx.com2010Boston, United States$84M115
Developer of peptide therapeutics for the treatment of rare genetic deficiencies
Premium access

Detailed competitors of Nexus BioPharma

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Metabolic Diseases

3 companies that operate in the same segment as Nexus BioPharma (Metabolic Diseases) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Satiety induction through digestable gastric balloon introduced via a swallowed capsule
2009Wellesley, Massachusetts, United StatesUSD 174.04 MUSD 32.11 M137
Developer of peptide therapeutics for the treatment of rare genetic deficiencies
2010Boston, Massachusetts, United StatesUSD 84 MUSD 189.76 M283
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Nexus BioPharma

Nexus BioPharma was founded in 2007.

Nexus BioPharma is headquartered in Montclair, United States. It is registered at Montclair, New Jersey, United States.

Nexus BioPharma has 1 employees.

Nexus BioPharma was founded in 2007 as a preclinical-stage biotechnology company located in Montclair, United States. Focus is placed on discovering and developing Fyn kinase inhibitors to activate the LKB1-AMPK metabolic pathway for treating obesity and type 2 diabetes. Operations involve collaboration with BioFocus DPI, a subsidiary of Charles River Laboratories, to advance these therapies.

Nexus BioPharma's top competitors include Rhythm Pharmaceuticals, MannKind Corp and NGM Biopharmaceuticals.

Nexus BioPharma offers Obesity Therapies and Diabetes Therapies.

Nexus BioPharma operates through Nexus Biopharma Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available